XML 27 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Valuation
9 Months Ended
Sep. 30, 2018
Fair Value Disclosures [Abstract]  
Valuation
Valuation
The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at September 30, 2018:
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
 
 
(In thousands)
Assets:
 
 
 
 
 
 
 
 
Cash equivalents
 
$
8,502

 
$

 
$

 
$
8,502

Investments, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
1,239,211

 
$
8,779

 
$
1,247,990

U.S. Treasury securities
 

 
4,230

 

 
4,230

Private label residential mortgage-backed securities
 

 
246,992

 
121,274

 
368,266

Private label commercial mortgage-backed securities
 

 
30,190

 
983

 
31,173

Commercial mortgage loans
 

 

 
125,808

 
125,808

Residential mortgage loans
 

 

 
392,460

 
392,460

Collateralized loan obligations
 

 
127,076

 
29,011

 
156,087

Consumer loans and asset-backed securities backed by consumer loans
 

 

 
204,504

 
204,504

Corporate debt
 

 
46,037

 
7,681

 
53,718

Secured notes
 

 

 
11,065

 
11,065

Real estate owned
 

 

 
34,944

 
34,944

Corporate equity investments
 
669

 

 
39,155

 
39,824

Total investments, at fair value
 
669

 
1,693,736

 
975,664

 
2,670,069

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
 

 

 
1,515

 
1,515

Credit default swaps on corporate bond indices
 

 
1,596

 

 
1,596

Credit default swaps on corporate bonds
 

 
5,406

 

 
5,406

Credit default swaps on asset-backed indices
 

 
3,063

 

 
3,063

Total return swaps
 

 
2

 

 
2

Interest rate swaps
 

 
17,918

 

 
17,918

Options
 

 
1

 

 
1

Futures
 
1,540

 

 

 
1,540

Forwards
 

 
297

 

 
297

Total financial derivatives–assets, at fair value
 
1,540

 
28,283

 
1,515

 
31,338

Repurchase agreements, at fair value
 

 
160,422

 

 
160,422

Total investments, financial derivatives–assets, and repurchase agreements, at fair value
 
$
2,209

 
$
1,882,441

 
$
977,179

 
$
2,861,829

Liabilities:
 
 
 
 
 
 
 
 
Investments sold short, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
(562,098
)
 
$

 
$
(562,098
)
Government debt
 

 
(72,442
)
 

 
(72,442
)
Corporate debt
 

 
(37,402
)
 

 
(37,402
)
Common stock
 
(23,407
)
 

 

 
(23,407
)
Total investments sold short, at fair value
 
(23,407
)
 
(671,942
)
 

 
(695,349
)
 
 
 
 
 
 
 
 
 
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
(continued)
 
(In thousands)
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on corporate bond indices
 
$

 
$
(9,797
)
 
$

 
$
(9,797
)
Credit default swaps on corporate bonds
 

 
(7,218
)
 

 
(7,218
)
Credit default swaps on asset-backed indices
 

 
(718
)
 

 
(718
)
Interest rate swaps
 

 
(7,694
)
 

 
(7,694
)
Total return swaps
 

 
(1,740
)
 

 
(1,740
)
Futures
 
(1
)
 

 

 
(1
)
Forwards
 

 
(58
)
 

 
(58
)
Total financial derivatives–liabilities, at fair value
 
(1
)
 
(27,225
)
 

 
(27,226
)
Other secured borrowings, at fair value
 

 

 
(89,569
)
 
(89,569
)
Total investments sold short, financial derivatives–liabilities, and other secured borrowings, at fair value
 
$
(23,408
)
 
$
(699,167
)
 
$
(89,569
)
 
$
(812,144
)

The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of September 30, 2018:
 
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
 
Min
 
Max
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Private label residential mortgage-backed securities
 
$
63,805

 
Market Quotes
 
Non Binding Third-Party Valuation
 
$
3.00

 
$
175.71

 
$
76.13

Collateralized loan obligations
 
22,934

 
Market Quotes
 
Non Binding Third-Party Valuation
 
61.00

 
96.25

 
68.09

Corporate debt, non-exchange traded corporate equity, and secured notes
 
14,981

 
Market Quotes
 
Non Binding Third-Party Valuation
 
9.88

 
91.00

 
61.00

Private label commercial mortgage-backed securities
 
539

 
Market Quotes
 
Non Binding Third-Party Valuation
 
5.11

 
6.16

 
5.74

Agency interest only residential mortgage-backed securities
 
2,510

 
Market Quotes
 
Non Binding Third-Party Valuation
 
2.10

 
16.68

 
15.91

Private label residential mortgage-backed securities
 
57,469

 
Discounted Cash Flows
 
Yield
 
3.0
%
 
53.9
%
 
9.5
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
18.3
%
 
90.2
%
 
56.4
%
 
 
 
 
 
 
Projected Collateral Losses
 
0.0
%
 
50.2
%
 
8.4
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
1.7
%
 
11.9
%
 
8.0
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
7.7
%
 
54.9
%
 
27.2
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Private label commercial mortgage-backed securities
 
444

 
Discounted Cash Flows
 
Yield
 
9.0
%
 
26.0
%
 
18.5
%
 
 
 
 
 
 
Projected Collateral Losses
 
1.6
%
 
1.6
%
 
1.6
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
1.5
%
 
1.5
%
 
1.5
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
96.9
%
 
96.9
%
 
96.9
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Corporate debt and non-exchange traded corporate equity
 
5,337

 
Discounted Cash Flows
 
Yield
 
17.1
%
 
17.1
%
 
17.1
%
(continued)
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
 
Min
 
Max
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Collateralized loan obligations
 
$
6,077

 
Discounted Cash Flows
 
Yield
 
8.5
%
 
17.6
%
 
11.7
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
90.2
%
 
94.1
%
 
91.5
%
 
 
 
 
 
 
Projected Collateral Losses
 
0.9
%
 
6.4
%
 
4.7
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
2.7
%
 
3.3
%
 
3.0
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
%
 
3.8
%
 
0.8
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Consumer loans and asset-backed securities backed by consumer loans
 
204,504

 
Discounted Cash Flows
 
Yield
 
7.0
%
 
12.0
%
 
8.4
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
44.4
%
 
34.9
%
 
 
 
 
 
 
Projected Collateral Losses
 
3.5
%
 
62.0
%
 
9.1
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
36.5
%
 
92.3
%
 
56.0
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Performing commercial mortgage loans
 
122,269

 
Discounted Cash Flows
 
Yield
 
8.0
%
 
21.4
%
 
10.9
%
Non-performing commercial mortgage loans and commercial real estate owned
 
37,097

 
Discounted Cash Flows
 
Yield
 
11.6
%
 
18.1
%
 
14.2
%
 
 
 
 
 
 
Months to Resolution
 
4.0

 
9.0

 
6.5

Performing residential mortgage loans
 
284,719

 
Discounted Cash Flows
 
Yield
 
4.0
%
 
12.8
%
 
5.8
%
Securitized residential mortgage loans(1)
 
94,965

 
Discounted Cash Flows
 
Yield
 
5.2
%
 
5.2
%
 
5.2
%
Non-performing residential mortgage loans and residential real estate owned
 
14,162

 
Discounted Cash Flows
 
Yield
 
4.6
%
 
20.9
%
 
9.0
%
 
 
 
 
 
 
Months to Resolution(2)
 
15.2

 
47.3

 
28.9

Credit default swaps on asset-backed securities
 
1,515

 
Net Discounted Cash Flows
 
Projected Collateral Prepayments
 
%
 
42.0
%
 
36.7
%
 
 
 
 
 
 
Projected Collateral Losses
 
10.6
%
 
16.5
%
 
13.2
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
9.7
%
 
18.2
%
 
16.7
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
30.9
%
 
37.7
%
 
33.4
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Agency interest only residential mortgage-backed securities
 
6,269

 
Option Adjusted Spread ("OAS")
 
LIBOR OAS(3)
 
211

 
3,521

 
753

 
 
 
 
 
 
Projected Collateral Prepayments
 
38.4
%
 
100.0
%
 
66.6
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
61.6
%
 
33.4
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded common equity investment in mortgage-related entity
 
2,814

 
Enterprise Value
 
Equity Price-to-Book(4)
 
1.5x
 
1.5x
 
1.5x
Non-exchange traded preferred equity investment in mortgage-related entity
 
27,357

 
Enterprise Value
 
Equity Price-to-Book(4)
 
1.0x
 
1.0x
 
1.0x
Non-controlling equity interest in limited liability company
 
7,412

 
Discounted Cash Flows
 
Yield(5)
 
10.6%
 
12.8%
 
10.9%
Other secured borrowings, at fair value(1)
 
(89,569
)
 
Discounted Cash Flows
 
Yield
 
4.0%
 
4.0%
 
4.0%

(1)
Securitized residential mortgage loans and Other secured borrowings, at fair value, represent financial assets and liabilities of the Company's CFE as discussed in Note 2.
(2)
Excludes certain loans that are re-performing.
(3)
Shown in basis points.
(4)
Represent an estimation of where market participants might value an enterprise on a price-to-book basis.
(5)
Represents the significant unobservable inputs used to fair value the financial instruments of the limited liability company. The fair value of such financial instruments is the largest component of the valuation of the limited liability company as a whole.
Third-party non-binding valuations are validated by comparing such valuations to internally generated prices based on the Company's models and to recent trading activity in the same or similar instruments.
For those instruments valued using discounted and net discounted cash flows, collateral prepayments, losses, recoveries, and scheduled amortization are projected over the remaining life of the collateral and expressed as a percentage of the collateral's current principal balance. Averages are weighted based on the fair value of the related instrument. In the case of credit default swaps on asset-backed securities, averages are weighted based on each instrument's bond equivalent value. Bond equivalent value represents the investment amount of a corresponding position in the reference obligation, calculated as the difference between the outstanding principal balance of the underlying reference obligation and the fair value, inclusive of accrued interest, of the derivative contract. For those assets valued using the LIBOR Option Adjusted Spread ("OAS") valuation methodology, cash flows are projected using the Company's models over multiple interest rate scenarios, and these projected cash flows are then discounted using the LIBOR rates implied by each interest rate scenario. The LIBOR OAS of an asset is then computed as the unique constant yield spread that, when added to all LIBOR rates in each interest rate scenario generated by the model, will equate (a) the expected present value of the projected asset cash flows over all model scenarios to (b) the actual current market price of the asset. LIBOR OAS is therefore model-dependent. Generally speaking, LIBOR OAS measures the additional yield spread over LIBOR that an asset provides at its current market price after taking into account any interest rate options embedded in the asset. The Company considers the expected timeline to resolution in the determination of fair value for its non-performing commercial and residential loans.
Material changes in any of the inputs above in isolation could result in a significant change to reported fair value measurements. Additionally, fair value measurements are impacted by the interrelationships of these inputs. For example, for instruments subject to prepayments and credit losses, such as non-Agency RMBS and consumer loans and ABS backed by consumer loans, a higher expectation of collateral prepayments will generally be accompanied by a lower expectation of collateral losses. Conversely, higher losses will generally be accompanied by lower prepayments. Because the Company's credit default swaps on asset-backed security holdings represent credit default swap contracts whereby the Company has purchased credit protection, such credit default swaps on asset-backed securities generally have the directionally opposite sensitivity to prepayments, losses, and recoveries as compared to the Company's long securities holdings. Prepayments do not represent a significant input for the Company's commercial mortgage-backed securities and commercial mortgage loans. Losses and recoveries do not represent a significant input for the Company's Agency RMBS interest only securities, given the guarantee of the issuing government agency or government-sponsored enterprise.
The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at December 31, 2017:
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
 
 
(In thousands)
Assets:
 
 
 
 
 
 
 
 
Cash equivalents
 
$
26,500

 
$

 
$

 
$
26,500

Investments, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
989,341

 
$
6,173

 
$
995,514

Private label residential mortgage-backed securities
 

 
158,369

 
101,297

 
259,666

Private label commercial mortgage-backed securities
 

 
28,398

 
12,347

 
40,745

Commercial mortgage loans
 

 

 
108,301

 
108,301

Residential mortgage loans
 

 

 
182,472

 
182,472

Collateralized loan obligations
 

 
185,905

 
24,911

 
210,816

Consumer loans and asset-backed securities backed by consumer loans
 

 

 
135,258

 
135,258

Corporate debt
 

 
51,246

 
23,947

 
75,193

Real estate owned
 

 

 
26,277

 
26,277

Corporate equity investments
 

 

 
37,465

 
37,465

Total investments, at fair value
 

 
1,413,259

 
658,448

 
2,071,707

 
 
 
 
 
 
 
 
 
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
(continued)
 
(In thousands)
Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
 
$

 
$

 
$
3,140

 
$
3,140

Credit default swaps on corporate bond indices
 

 
1,429

 

 
1,429

Credit default swaps on corporate bonds
 

 
8,888

 

 
8,888

Credit default swaps on asset-backed indices
 

 
5,393

 

 
5,393

Interest rate swaps
 

 
9,266

 

 
9,266

Options
 
3

 
1

 

 
4

Futures
 
45

 

 

 
45

Total financial derivatives–assets, at fair value
 
48

 
24,977

 
3,140

 
28,165

Repurchase agreements, at fair value
 

 
155,949

 

 
155,949

Total investments, financial derivatives–assets, and repurchase agreements, at fair value
 
$
48

 
$
1,594,185

 
$
661,588

 
$
2,255,821

Liabilities:
 
 
 
 
 
 
 
 
Investments sold short, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
(460,189
)
 
$

 
$
(460,189
)
Government debt
 

 
(90,149
)
 

 
(90,149
)
Corporate debt
 

 
(55,211
)
 

 
(55,211
)
Common stock
 
(36,691
)
 

 

 
(36,691
)
Total investments sold short, at fair value
 
(36,691
)
 
(605,549
)
 

 
(642,240
)
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on corporate bond indices
 

 
(12,367
)
 

 
(12,367
)
Credit default swaps on corporate bonds
 

 
(15,930
)
 

 
(15,930
)
Credit default swaps on asset-backed indices
 

 
(980
)
 

 
(980
)
Interest rate swaps
 

 
(6,015
)
 

 
(6,015
)
Futures
 
(508
)
 

 

 
(508
)
Forwards
 

 
(473
)
 

 
(473
)
Total financial derivatives–liabilities, at fair value
 
(508
)
 
(35,765
)
 

 
(36,273
)
Other secured borrowings, at fair value
 

 

 
(125,105
)
 
(125,105
)
Total investments sold short, financial derivatives–liabilities, and other secured borrowings, at fair value
 
$
(37,199
)
 
$
(641,314
)
 
$
(125,105
)
 
$
(803,618
)


The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of December 31, 2017:
 
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
 
Min
 
Max
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Private label residential mortgage-backed securities
 
$
40,870

 
Market Quotes
 
Non Binding Third-Party Valuation
 
$
45.00

 
$
183.00

 
$
81.63

Collateralized loan obligations
 
10,288

 
Market Quotes
 
Non Binding Third-Party Valuation
 
85.00

 
435.00

 
138.94

Corporate debt and non-exchange traded corporate equity
 
6,797

 
Market Quotes
 
Non Binding Third-Party Valuation
 
8.88

 
105.63

 
82.94

Private label commercial mortgage-backed securities
 
7,577

 
Market Quotes
 
Non Binding Third-Party Valuation
 
5.31

 
60.55

 
36.19

Agency interest only residential mortgage-backed securities
 
1,225

 
Market Quotes
 
Non Binding Third-Party Valuation
 
10.14

 
18.21

 
15.25

Private label residential mortgage-backed securities
 
60,427

 
Discounted Cash Flows
 
Yield
 
0.5
%
 
26.5
%
 
9.8
%
 
 

 
 
 
Projected Collateral Prepayments
 
2.1
%
 
84.7
%
 
38.3
%
 
 
 
 
 
 
Projected Collateral Losses
 
0.9
%
 
18.2
%
 
8.6
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
0.3
%
 
31.5
%
 
11.3
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
12.5
%
 
90.2
%
 
41.8
%
 
 
 
 
 
 
 
 

 

 
100.0
%
Private label commercial mortgage-backed securities
 
4,770

 
Discounted Cash Flows
 
Yield
 
4.3
%
 
42.5
%
 
18.6
%
 
 


 
 
 
Projected Collateral Losses
 
1.1
%
 
5.2
%
 
2.5
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
2.8
%
 
17.1
%
 
8.5
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
80.1
%
 
96.1
%
 
89.0
%
 
 
 
 
 
 
 
 


 


 
100.0
%
Corporate debt and non-exchange traded corporate equity
 
20,301

 
Discounted Cash Flows
 
Yield
 
3.0
%
 
16.1
%
 
10.6
%
Collateralized loan obligations
 
14,623

 
Discounted Cash Flows
 
Yield
 
7.1
%
 
62.2
%
 
15.2
%
 
 


 
 
 
Projected Collateral Prepayments
 
22.5
%
 
92.9
%
 
77.9
%
 
 
 
 
 
 
Projected Collateral Losses
 
1.9
%
 
40.2
%
 
10.3
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
3.4
%
 
37.2
%
 
9.5
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
%
 
4.1
%
 
2.3
%
 
 
 
 
 
 
 
 


 


 
100.0
%
Consumer loans and asset-backed securities backed by consumer loans
 
135,258

 
Discounted Cash Flows
 
Yield
 
7.0
%
 
18.9
%
 
9.5
%
 
 

 
 
 
Projected Collateral Prepayments
 
2.2
%
 
50.1
%
 
33.5
%
 
 
 
 
 
 
Projected Collateral Losses
 
0.4
%
 
28.6
%
 
8.2
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
46.8
%
 
95.2
%
 
58.3
%
 
 
 
 
 
 
 
 


 


 
100.0
%
Performing commercial mortgage loans
 
84,377

 
Discounted Cash Flows
 
Yield
 
8.0
%
 
15.4
%
 
10.7
%
Non-performing commercial mortgage loans and commercial real estate owned
 
49,610

 
Discounted Cash Flows
 
Yield
 
11.4
%
 
36.5
%
 
17.7
%
 
 

 
 
 
Months to Resolution
 
4.0

 
17.0

 
9.5

(continued)
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
 
Min
 
Max
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Performing residential mortgage loans
 
$
42,030

 
Discounted Cash Flows
 
Yield
 
1.6
%
 
18.8
%
 
6.2
%
Securitized residential mortgage loans(1)
 
132,424

 
Discounted Cash Flows
 
Yield
 
3.5
%
 
3.5
%
 
3.5
%
Non-performing residential mortgage loans and residential real estate owned
 
8,609

 
Discounted Cash Flows
 
Yield
 
2.8
%
 
34.5
%
 
8.9
%
 
 
 
 
 
 
Months to Resolution(2)
 
1.9

 
40.5

 
25.6

Credit default swaps on asset-backed securities
 
3,140

 
Net Discounted Cash Flows
 
Projected Collateral Prepayments
 
19.8
%
 
26.5
%
 
22.4
%
 
 
 
 
 
 
Projected Collateral Losses
 
14.6
%
 
23.8
%
 
19.7
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
5.8
%
 
14.3
%
 
10.6
%
 
 


 
 
 
Projected Collateral Scheduled Amortization
 
45.5
%
 
51.0
%
 
47.3
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Agency interest only residential mortgage-backed securities
 
4,948

 
Option Adjusted Spread ("OAS")
 
LIBOR OAS(3)
 
381

 
3,521

 
730

 
 
 
 
 
 
Projected Collateral Prepayments
 
51.2
%
 
100.0
%
 
69.1
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
48.8
%
 
30.9
%
 
 

 
 
 
 
 
 
 


 
100.0
%
Non-exchange traded common equity investment in mortgage-related entity
 
2,814

 
Enterprise Value
 
Equity Price-to-Book(4)
 
2.0x
 
2.0x
 
2.0x
Non-exchange traded preferred equity investment in mortgage-related entity
 
20,774

 
Enterprise Value
 
Equity Price-to-Book(4)
 
0.9x
 
0.9x
 
0.9x
Non-controlling equity interest in limited liability company
 
5,033

 
Market Quotes
 
Non Binding Third-Party Valuation of the Underlying Assets(5)
 
$
96.91

 
$
96.91

 
$
96.91

Non-controlling equity interest in limited liability company
 
5,693

 
Discounted Cash Flows
 
Yield(5)
 
9.1%
 
9.1%
 
9.1%
Other secured borrowings, at fair value(1)
 
(125,105
)
 
Discounted Cash Flows
 
Yield
 
2.8%
 
2.8%
 
2.8%
(1)
Securitized residential mortgage loans and Other secured borrowings, at fair value, represent financial assets and liabilities of the Company's CFE as discussed in Note 2.
(2)
Excludes certain loans that are re-performing.
(3)
Shown in basis points.
(4)
Represent an estimation of where market participants might value an enterprise on a price-to-book basis.
(5)
Represents the significant unobservable inputs used to fair value the financial instruments of the limited liability company. The fair value of such financial instruments is the largest component of the valuation of the limited liability company as a whole.
Third-party non-binding valuations are validated by comparing such valuations to internally generated prices based on the Company's models and to recent trading activity in the same or similar instruments.
For those instruments valued using discounted and net discounted cash flows, collateral prepayments, losses, recoveries, and scheduled amortization are projected over the remaining life of the collateral and expressed as a percentage of the collateral's current principal balance. Averages are weighted based on the fair value of the related instrument. In the case of credit default swaps on asset-backed securities, averages are weighted based on each instrument's bond equivalent value. Bond equivalent value represents the investment amount of a corresponding position in the reference obligation, calculated as the difference between the outstanding principal balance of the underlying reference obligation and the fair value, inclusive of accrued interest, of the derivative contract. For those assets valued using the LIBOR OAS valuation methodology, cash flows are projected using the Company's models over multiple interest rate scenarios, and these projected cash flows are then discounted using the LIBOR rates implied by each interest rate scenario. The LIBOR OAS of an asset is then computed as the unique constant yield spread that, when added to all LIBOR rates in each interest rate scenario generated by the model, will equate (a) the expected present value of the projected asset cash flows over all model scenarios to (b) the actual current market price of the asset. LIBOR OAS is therefore model-dependent. Generally speaking, LIBOR OAS measures the additional yield spread over LIBOR that an asset provides at its current market price after taking into account any interest rate options embedded in the asset.
Material changes in any of the inputs above in isolation could result in a significant change to reported fair value measurements. Additionally, fair value measurements are impacted by the interrelationships of these inputs. For example, for instruments subject to prepayments and credit losses, such as non-Agency RMBS and consumer loans and ABS backed by consumer loans, a higher expectation of collateral prepayments will generally be accompanied by a lower expectation of collateral losses. Conversely, higher losses will generally be accompanied by lower prepayments. Because the Company's credit default swaps on asset-backed security holdings represent credit default swap contracts whereby the Company has purchased credit protection, such credit default swaps on asset-backed securities generally have the directionally opposite sensitivity to prepayments, losses, and recoveries as compared to the Company's long securities holdings. Prepayments do not represent a significant input for the Company's commercial mortgage-backed securities and commercial mortgage loans. Losses and recoveries do not represent a significant input for the Company's Agency RMBS interest only securities, given the guarantee of the issuing government agency or government-sponsored enterprise.
The tables below include a roll-forward of the Company's financial instruments for the three- and nine-month periods ended September 30, 2018 and 2017 (including the change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy.
Level 3—Fair Value Measurement Using Significant Unobservable Inputs:
Three-Month Period Ended September 30, 2018
(In thousands)
Ending
Balance as of 
June 30, 2018
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
September 30, 2018
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
5,889

 
$
(509
)
 
$
(24
)
 
$
(67
)
 
$
773

 
$
(209
)
 
$
3,981

 
$
(1,055
)
 
$
8,779

Private label residential mortgage-backed securities
96,396

 
(206
)
 
335

 
(1,181
)
 
48,860

 
(16,726
)
 
3,942

 
(10,146
)
 
121,274

Private label commercial mortgage-backed securities
8,761

 
4

 
198

 
494

 

 
(2,415
)
 

 
(6,059
)
 
983

Commercial mortgage loans
104,951

 
(300
)
 
252

 
522

 
36,571

 
(16,188
)
 

 

 
125,808

Residential mortgage loans
293,472

 
(513
)
 
25

 
(400
)
 
117,101

 
(17,225
)
 

 

 
392,460

Collateralized loan obligations
6,109

 
302

 
(25
)
 
(491
)
 
24,115

 
(3,183
)
 
2,184

 

 
29,011

Consumer loans and asset-backed securities backed by consumer loans
199,254

 
(8,012
)
 
7,555

 
(7,615
)
 
54,503

 
(41,181
)
 

 

 
204,504

Corporate debt
8,850

 
13

 
87

 
(280
)
 
6,780

 
(7,769
)
 

 

 
7,681

Secured notes
11,126

 
405

 

 
(466
)
 

 

 

 

 
11,065

Real estate owned
34,339

 

 
(81
)
 
331

 
475

 
(120
)
 

 

 
34,944

Corporate equity investments
44,768

 

 
487

 
(377
)
 

 
(5,723
)
 

 

 
39,155

Total investments, at fair value
813,915

 
(8,816
)
 
8,809

 
(9,530
)
 
289,178

 
(110,739
)
 
10,107

 
(17,260
)
 
975,664

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
2,591

 

 
(986
)
 
1,307

 
27

 
(1,424
)
 

 

 
1,515

Total financial derivatives– assets, at fair value
2,591

 

 
(986
)
 
1,307

 
27

 
(1,424
)
 

 

 
1,515

Total investments and financial derivatives–assets, at fair value
$
816,506

 
$
(8,816
)
 
$
7,823

 
$
(8,223
)
 
$
289,205

 
$
(112,163
)
 
$
10,107

 
$
(17,260
)
 
$
977,179

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other secured borrowings, at fair value
$
(101,100
)
 
$

 
$

 
$
(358
)
 
$
11,889

 
$

 
$

 
$

 
$
(89,569
)
Total other secured borrowings, at fair value
$
(101,100
)
 
$

 
$

 
$
(358
)
 
$
11,889

 
$

 
$

 
$

 
$
(89,569
)
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at September 30, 2018, as well as Level 3 financial instruments disposed of by the Company during the three-month period ended September 30, 2018. For Level 3 financial instruments held by the Company at September 30, 2018, change in net unrealized gain (loss) of $(2.4) million, $(0.1) million, and $(0.4) million, for the three-month period ended September 30, 2018 relate to investments, financial derivatives–assets, and other secured borrowings, at fair value, respectively.
At September 30, 2018, the Company transferred $17.3 million of securities from Level 3 to Level 2 and $10.1 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third party pricing sources.
Three-Month Period Ended September 30, 2017
(In thousands)
Ending
Balance as of 
June 30, 2017
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
September 30, 2017
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
4,896

 
$
(377
)
 
$
(78
)
 
$

 
$
1,649

 
$
(28
)
 
$
772

 
$
(1,015
)
 
$
5,819

Private label residential mortgage-backed securities
79,123

 
261

 
1,018

 
409

 
3,040

 
(9,116
)
 
5,207

 
(6,294
)
 
73,648

Private label commercial mortgage-backed securities
13,809

 
(144
)
 
(752
)
 
934

 
2,100

 
(5,718
)
 
1,713

 
(310
)
 
11,632

Commercial mortgage loans
65,896

 
140

 

 
17

 
4,342

 
(2,500
)
 

 

 
67,895

Residential mortgage loans
136,097

 
(874
)
 
388

 
(1,013
)
 
37,170

 
(8,805
)
 

 

 
162,963

Collateralized loan obligations
42,536

 
346

 
61

 
(839
)
 
7,108

 
(13,416
)
 

 
(8,878
)
 
26,918

Consumer loans and asset-backed securities backed by consumer loans
108,671

 
(3,366
)
 
500

 
(528
)
 
33,125

 
(22,062
)
 

 

 
116,340

Corporate debt
20,535

 
(19
)
 
128

 
(415
)
 
409

 
(7,730
)
 

 

 
12,908

Real estate owned
24,977

 

 

 
49

 
1,137

 
(401
)
 

 

 
25,762

Corporate equity investments
35,698

 

 
329

 
(806
)
 
4,641

 
(2,535
)
 

 

 
37,327

Total investments, at fair value
532,238

 
(4,033
)
 
1,594

 
(2,192
)
 
94,721

 
(72,311
)
 
7,692

 
(16,497
)
 
541,212

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
5,107

 

 
603

 
(577
)
 
27

 
(630
)
 

 

 
4,530

Total return swaps

 

 
21

 

 

 
(21
)
 

 

 

Total financial derivatives– assets, at fair value
5,107

 

 
624

 
(577
)
 
27

 
(651
)
 

 

 
4,530

Total investments and financial derivatives–assets, at fair value
$
537,345

 
$
(4,033
)
 
$
2,218

 
$
(2,769
)
 
$
94,748

 
$
(72,962
)
 
$
7,692

 
$
(16,497
)
 
$
545,742

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(207
)
 
$

 
$
(20
)
 
$

 
$
20

 
$

 
$

 
$

 
$
(207
)
Total return swaps

 

 
13

 

 
(13
)
 

 

 

 

Total financial derivatives– liabilities, at fair value
$
(207
)
 
$

 
$
(7
)
 
$

 
$
7

 
$

 
$

 
$

 
$
(207
)
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at September 30, 2017, as well as Level 3 financial instruments disposed of by the Company during the three-month period ended September 30, 2017. For Level 3 financial instruments held by the Company at September 30, 2017, change in net unrealized gain (loss) of $(2.9) million and $(0.6) million for the three-month period ended September 30, 2017 relate to investments and financial derivatives–assets, respectively.
At September 30, 2017, the Company transferred $16.5 million of securities from Level 3 to Level 2 and $7.7 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources.
Nine-Month Period Ended September 30, 2018
(In thousands)
Ending
Balance as of 
December 31, 2017
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
September 30, 2018
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
6,173

 
$
(1,711
)
 
$
34

 
$
206

 
$
2,751

 
$
(1,166
)
 
$
3,981

 
$
(1,489
)
 
$
8,779

Private label residential mortgage-backed securities
101,297

 
1

 
2,836

 
(2,392
)
 
76,816

 
(43,723
)
 
7,139

 
(20,700
)
 
121,274

Private label commercial mortgage-backed securities
12,347

 
(225
)
 
1,815

 
2,111

 
1,480

 
(16,305
)
 

 
(240
)
 
983

Commercial mortgage loans
108,301

 
545

 
1,135

 
971

 
60,691

 
(45,835
)
 

 

 
125,808

Residential mortgage loans
182,472

 
(1,692
)
 
608

 
(1,319
)
 
266,925

 
(54,534
)
 

 

 
392,460

Collateralized loan obligations
24,911

 
345

 
826

 
(991
)
 
47,837

 
(30,309
)
 

 
(13,608
)
 
29,011

Consumer loans and asset-backed securities backed by consumer loans
135,258

 
(20,864
)
 
8,506

 
(30
)
 
179,706

 
(98,072
)
 

 

 
204,504

Corporate debt
23,947

 

 
235

 
(709
)
 
7,684

 
(16,419
)
 

 
(7,057
)
 
7,681

Secured notes

 
497

 

 
(700
)
 
11,268

 

 

 

 
11,065

Real estate owned
26,277

 

 
(527
)
 
945

 
10,045

 
(1,796
)
 

 

 
34,944

Corporate equity investments
37,465

 

 
1,669

 
3,948

 
9,078

 
(13,005
)
 

 

 
39,155

Total investments, at fair value
658,448

 
(23,104
)
 
17,137

 
2,040

 
674,281

 
(321,164
)
 
11,120

 
(43,094
)
 
975,664

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
3,140

 

 
(739
)
 
759

 
72

 
(1,717
)
 

 

 
1,515

Total financial derivatives– assets, at fair value
3,140

 

 
(739
)
 
759

 
72

 
(1,717
)
 

 

 
1,515

Total investments and financial derivatives–assets, at fair value
$
661,588

 
$
(23,104
)
 
$
16,398

 
$
2,799

 
$
674,353

 
$
(322,881
)
 
$
11,120

 
$
(43,094
)
 
$
977,179

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other secured borrowings, at fair value
$
(125,105
)
 
$

 
$

 
$
840

 
$
34,696

 
$

 
$

 
$

 
$
(89,569
)
Total other secured borrowings, at fair value
$
(125,105
)
 
$

 
$

 
$
840

 
$
34,696

 
$

 
$

 
$

 
$
(89,569
)

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at September 30, 2018, as well as Level 3 financial instruments disposed of by the Company during the nine-month period ended September 30, 2018. For Level 3 financial instruments held by the Company at September 30, 2018, change in net unrealized gain (loss) of $1.8 million, $(0.6) million, and $0.8 million, for the nine-month period ended September 30, 2018 relate to investments, financial derivatives–assets, and other secured borrowings, at fair value, respectively.
At September 30, 2018, the Company transferred $43.1 million of securities from Level 3 to Level 2 and $11.1 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third party pricing sources.
Nine-Month Period Ended September 30, 2017
(In thousands)
Ending
Balance as of 
December 31, 2016
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in
Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
September 30, 2017
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
29,622

 
$
(7,233
)
 
$
(515
)
 
$
(140
)
 
$
3,962

 
$
(153
)
 
$

 
$
(19,724
)
 
$
5,819

Private label residential mortgage-backed securities
90,083

 
1,672

 
1,334

 
7,319

 
31,117

 
(37,278
)
 
15,043

 
(35,642
)
 
73,648

Private label commercial mortgage-backed securities
43,268

 
574

 
(3,434
)
 
7,873

 
2,120

 
(31,542
)
 

 
(7,227
)
 
11,632

Commercial mortgage loans
61,129

 
771

 
416

 
1,167

 
31,887

 
(27,475
)
 

 

 
67,895

Residential mortgage loans
84,290

 
(196
)
 
1,469

 
(1,090
)
 
108,356

 
(29,866
)
 

 

 
162,963

Collateralized loan obligations
44,956

 
(5,702
)
 
1,477

 
2,135

 
52,269

 
(54,305
)
 

 
(13,912
)
 
26,918

Consumer loans and asset-backed securities backed by consumer loans
107,157

 
(9,631
)
 
426

 
(247
)
 
83,138

 
(64,503
)
 

 

 
116,340

Corporate debt
25,004

 
236

 
676

 
(229
)
 
83,900

 
(96,679
)
 

 

 
12,908

Real estate owned
3,349

 

 
424

 
(246
)
 
25,348

 
(3,113
)
 

 

 
25,762

Corporate equity investments
29,392

 

 
1,848

 
(1,529
)
 
16,416

 
(8,800
)
 

 

 
37,327

Total investments, at fair value
518,250

 
(19,509
)
 
4,121

 
15,013

 
438,513

 
(353,714
)
 
15,043

 
(76,505
)
 
541,212

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
5,326

 

 
971

 
(796
)
 
95

 
(1,066
)
 

 

 
4,530

Total return swaps
155

 

 
243

 
(155
)
 

 
(243
)
 

 

 

Warrants
106

 

 
(100
)
 
(6
)
 

 

 

 

 

Total financial derivatives– assets, at fair value
5,587

 

 
1,114

 
(957
)
 
95

 
(1,309
)
 

 

 
4,530

Total investments and financial derivatives–assets, at fair value
$
523,837

 
$
(19,509
)
 
$
5,235

 
$
14,056

 
$
438,608

 
$
(355,023
)
 
$
15,043

 
$
(76,505
)
 
$
545,742

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial derivatives– liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(256
)
 
$

 
$
(485
)
 
$
477

 
$
485

 
$
(428
)
 
$

 
$

 
$
(207
)
Total return swaps
(249
)
 

 
(279
)
 
249

 
291

 
(12
)
 

 

 

Total financial derivatives– liabilities, at fair value
$
(505
)
 
$

 
$
(764
)
 
$
726

 
$
776

 
$
(440
)
 
$

 
$

 
$
(207
)

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at September 30, 2017, as well as Level 3 financial instruments disposed of by the Company during the nine-month period ended September 30, 2017. For Level 3 financial instruments held by the Company at September 30, 2017, change in net unrealized gain (loss) of $2.8 million, $(0.8) million, and $49 thousand, for the nine-month period ended September 30, 2017 relate to investments, financial derivatives–assets, and financial derivatives–liabilities, respectively.
At September 30, 2017, the Company transferred $76.5 million of securities from Level 3 to Level 2 and $15.0 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources.
Not included in the disclosures above are the Company's other financial instruments, which are carried at cost and include, Cash, Due from brokers, Due to brokers, Reverse repurchase agreements, Other secured borrowings, and the Company's unsecured long-term debt, or the "Senior Notes," which is reflected on the Consolidated Statement of Assets, Liabilities, and Equity in Senior notes, net. Cash includes cash held in various accounts including an interest bearing overnight account for which fair value equals the carrying value; such assets are considered Level 1 assets. Due from brokers and Due to brokers include collateral transferred to or received from counterparties, along with receivables and payables for open and/or closed derivative positions. These receivables and payables are short term in nature and any collateral transferred consists primarily of cash; carrying value of these items approximates fair value and such items are considered Level 1 assets and liabilities. The Company's reverse repurchase agreements and Other secured borrowings are carried at cost, which approximates fair value due to their short term nature. Reverse repurchase agreements and Other secured borrowings are considered Level 2 assets and liabilities based on the adequacy of the associated collateral and their short term nature. The Company estimates the fair value of the Senior Notes at $85.6 million as of both September 30, 2018 and December 31, 2017. The Senior Notes are considered Level 3 liabilities given the relative unobservability of the most significant inputs to valuation estimation as well as the lack of trading activity of these instruments.